Pine Valley Investments’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$682K Sell
2,751
-173
-6% -$37.3K 0.03% 355
2026
Q1
$587K Sell
2,924
-319
-10% -$66K 0.03% 356
2025
Q4
$670K Sell
3,243
-144
-4% -$28.8K 0.03% 324
2025
Q3
$607K Sell
3,387
-260
-7% -$44.3K 0.03% 324
2025
Q2
$588K Buy
3,647
+8
+0.2% +$1.27K 0.03% 324
2025
Q1
$619K Buy
3,639
+6
+0.2% +$1.04K 0.04% 312
2024
Q4
$604K Buy
3,633
+150
+4% +$25.6K 0.04% 314
2024
Q3
$599K Buy
+3,483
New +$577K 0.04% 300
2024
Q2
Sell
-3,342
Closed -$514K 494
2024
Q1
$514K Buy
3,342
+39
+1% +$5.95K 0.03% 305
2023
Q4
$522K Buy
3,303
+46
+1% +$6.61K 0.04% 297
2023
Q3
$477K Sell
3,257
-14
-0.4% -$2.13K 0.04% 292
2023
Q2
$501K Sell
3,271
-1,308
-29% -$204K 0.05% 259
2023
Q1
$659K Buy
+4,579
New +$719K 0.1% 163

Other funds holding FBT

Pine Valley Investments's FBT Position: Q2 2026 in Review

Pine Valley Investments reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 5.9% in Q2 2026, selling an estimated $37.3K and leaving 2,751 shares worth $682K. The position accounts for 0.03% of the portfolio, ranked #355.

Pine Valley Investments first reported a position in FBT in Q1 2023 and has held it in 13 quarters since. 181 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Pine Valley Investments held 2,751 shares of First Trust NYSE Arca Biotechnology Index Fund worth $682K as of Q2 2026.
  • Pine Valley Investments sold 173 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $37.3K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.03% of Pine Valley Investments's portfolio in Q2 2026, its #355 holding.
  • Pine Valley Investments first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2023 and has held it in 13 quarters since.
  • 181 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.